Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Mortality and Myocardial Effects of Antidepressants Are Moderated by Preexisting Cardiovascular Disease: A Meta-Analysis
Marta M. Maslej, Benjamin M. Bolker, Marley J. Russell, et al.
Psychotherapy and Psychosomatics (2017) Vol. 86, Iss. 5, pp. 268-282
Closed Access | Times Cited: 89

Showing 26-50 of 89 citing articles:

Exploring the Role of Serotonin as an Immune Modulatory Component in Cardiovascular Diseases
Aqeela Imamdin, Emiel P. C. van der Vorst
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1549-1549
Open Access | Times Cited: 10
Current research progress, opportunities, and challenges of Limosillactobacillus reuteri -based probiotic dietary strategies
Luanfeng Wang, Bo Ren, Shufeng Wu, et al.
Critical Reviews in Food Science and Nutrition (2024), pp. 1-21
Closed Access | Times Cited: 3
Antidepressant and antipsychotic drug prescribing and diabetes outcomes: A systematic review of observational studies
Charlotte Greene, Hanna Ward-Penny, Marianna F. Ioannou, et al.
Diabetes Research and Clinical Practice (2023) Vol. 199, pp. 110649-110649
Open Access | Times Cited: 8
Precision Medicine in Lifestyle Medicine: The Way of the Future?
Ian D. Gray, Andrea R. Kross, Melanie Elise Renfrew, et al.
American Journal of Lifestyle Medicine (2019) Vol. 14, Iss. 2, pp. 169-186
Open Access | Times Cited: 25
Antidepressant treatment for primary care patients with depressive symptoms: Data from thediamondlongitudinal cohort study
Sandra Davidson, Helena Romaniuk, Patty Chondros, et al.
Australian & New Zealand Journal of Psychiatry (2020) Vol. 54, Iss. 4, pp. 367-381
Open Access | Times Cited: 22
Evolutionary theory and the treatment of depression: It is all about the squids and the sea bass
Steven D. Hollon, Paul W. Andrews, Daisy R. Singla, et al.
Behaviour Research and Therapy (2021) Vol. 143, pp. 103849-103849
Open Access | Times Cited: 18
Repeated use of SSRIs potentially associated with an increase on serum CK and CK-MB in patients with major depressive disorder: a retrospective study
Shengwei Wu, Yufang Zhou, Zhengzheng Xuan, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review
Michelle Bradbury, Brian Hutton, Ana-Alicia Beltran-Bless, et al.
Clinical Breast Cancer (2021) Vol. 22, Iss. 3, pp. e362-e373
Open Access | Times Cited: 16
Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression
Milan Stoiljković, Valentina Nikolić, Nebojša Ilić, et al.
Pharmacology (2023) Vol. 108, Iss. 4, pp. 409-414
Closed Access | Times Cited: 6
The Monoamine Hypothesis of Depression Revisited: Could It Mechanistically Novel Antidepressant Strategies?
Fiammetta Cosci, Guy Chouinard
Elsevier eBooks (2019), pp. 63-73
Closed Access | Times Cited: 19
Placebo nasal spray protects female participants from experimentally induced sadness and concomitant changes in autonomic arousal
Annelie C. Göhler, Julia W. Haas, Matthias F. J. Sperl, et al.
Journal of Affective Disorders (2021) Vol. 295, pp. 131-138
Closed Access | Times Cited: 13
Practical strategies to end coercive practices in mental health services
Michelle Funk, Natalie Drew
World Psychiatry (2019) Vol. 18, Iss. 1, pp. 43-44
Open Access | Times Cited: 15
Einsatzmöglichkeiten von Peerbegleitung in der psychiatrischen Versorgung
Candelaria Mahlke, Gwen Schulz, Gyöngyvér Sielaff, et al.
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2019) Vol. 62, Iss. 2, pp. 214-221
Closed Access | Times Cited: 15
Criterion-related validity in a sample of migraine outpatients: the diagnostic criteria for psychosomatic research
Fiammetta Cosci, Andrea Svicher, Sara Romanazzo, et al.
CNS Spectrums (2019) Vol. 25, Iss. 4, pp. 545-551
Closed Access | Times Cited: 14
Disordered doctors or rational rats? Testing adaptationist and disorder hypotheses for melancholic depression and their relevance for clinical psychology
Paul W. Andrews, Marta M. Maslej, J. Anderson Thomson, et al.
Clinical Psychology Review (2020) Vol. 82, pp. 101927-101927
Closed Access | Times Cited: 14
Neuropsychiatric disorders in patients with heart failure: not to be ignored
Theodora A. Manolis, Antonis A. Manolis, Helen Melita, et al.
Heart Failure Reviews (2022) Vol. 28, Iss. 4, pp. 821-858
Closed Access | Times Cited: 8
Patterns of filled prescriptions and the association with risk of drug‐induced death. A population‐based nested case‐control register study
Ellen J. Amundsen, Ingvild Odsbu, Svetlana Skurtveit, et al.
Pharmacoepidemiology and Drug Safety (2024) Vol. 33, Iss. 2
Open Access | Times Cited: 1
Generalization and enhancement of the effects of an active placebo nasal spray on sadness
Marcel Wilhelm, Staci A. Fischer, Winfried Rief, et al.
Journal of Affective Disorders (2024) Vol. 369, pp. 568-575
Open Access | Times Cited: 1
MENTAL DISORDERS AND CARDIOVASCULAR DISEASES: GUIDELINES OF THE BAIKAL PSYCHOSOMATIC ASSOCIATION AND THE SIBERIAN PSYCHOSOMATIC ASSOCIATION
Belialov Fi, А. Н. Сумин, Н. П. Гарганеева, et al.
Complex Issues of Cardiovascular Diseases (2024) Vol. 13, Iss. 3S, pp. 222-253
Closed Access | Times Cited: 1
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Reetta Kettunen, Heidi Taipale, Anna‐Maija Tolppanen, et al.
European Journal of Clinical Pharmacology (2018) Vol. 75, Iss. 3, pp. 417-425
Open Access | Times Cited: 11
Selective serotonin reuptake inhibitor use and mortality, postoperative complications, and quality of care in hip fracture patients: a Danish nationwide cohort study
Stine B Bruun, Irene Petersen, Nickolaj Risbo Kristensen, et al.
Clinical Epidemiology (2018) Vol. Volume 10, pp. 1053-1071
Open Access | Times Cited: 9
Benzodiazepine Use and Long-Term Mortality in Real-Life Chronic Heart Failure Outpatients: A Cohort Analysis
Crisanto Díez, Josep Lupón, Marta de Antonio, et al.
Psychotherapy and Psychosomatics (2018) Vol. 87, Iss. 6, pp. 372-374
Closed Access | Times Cited: 9
Predictors of successful discontinuation of antipsychotics and antidepressants
Tania M. Lincoln, Daniel Sommer, Mariana Quazzola, et al.
Psychological Medicine (2021) Vol. 53, Iss. 7, pp. 3085-3095
Open Access | Times Cited: 8
Antidepressants and Risk of Sudden Cardiac Death: A Network Meta-Analysis and Systematic Review
Narut Prasitlumkum, Wisit Cheungpasitporn, Nithi Tokavanich, et al.
Medical Sciences (2021) Vol. 9, Iss. 2, pp. 26-26
Open Access | Times Cited: 7
Treatment of Heart Failure Patients with Anxiolytics Is Associated with Adverse Outcomes, with and without Depression
Donna R. Zwas, Andre Keren, Offer Amir, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3967-3967
Open Access | Times Cited: 6

Scroll to top